Lindeman Brenessa M, Pesce Catherine E, Tsai Hua-Ling, Somervell Helina, Umbricht Christopher B, Kowalski Jeanne, Zeiger Martha A
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Am Surg. 2014 May;80(5):505-10.
Low vitamin D levels have been shown to be associated with primary hyperparathyroidism, but it is unclear whether vitamin D deficiency may be an etiologic factor in the development of primary hyperparathyroidism. To investigate this, we compared preoperative vitamin D levels of patients undergoing surgery for primary hyperparathyroidism with those of patients undergoing surgery for benign thyroid disease. With Institutional Review Board approval, data were collected prospectively on patients undergoing parathyroidectomy or thyroidectomy by one surgeon between March 2006 and July 2011. Patients were excluded if they underwent simultaneous thyroid and parathyroid surgery, had secondary or tertiary hyperparathyroidism, if no preoperative vitamin D level was measured, or if they took vitamin D supplements. Inclusion criteria were met by 219 patients who underwent parathyroidectomy and 186 patients who underwent thyroid surgery. Patient age, sex, race, and preoperative vitamin D levels (vitamin D 25-OH; normal, 32 to 100 pg/mL) were collected. Statistical analysis was performed using linear regression. Vitamin D levels were significantly lower in the parathyroid group compared with the thyroid group (23.8 vs 28.5 pg/mL; P < 0.001). This difference was also observed after adjustment for age, sex, and race with a mean difference of 4.87 pg/mL (P < 0.001). Statistically significant associations between lower vitamin D levels and patients younger than 50 years (P = 0.048), male sex (P = 0.03), and nonwhite race were identified (P < 0.001). Patients with primary hyperparathyroidism are more likely to have lower vitamin D levels than a control surgical population. Further study is needed to determine whether low vitamin D levels may be an etiologic factor associated with the development of hyperparathyroidism.
低维生素D水平已被证明与原发性甲状旁腺功能亢进有关,但维生素D缺乏是否可能是原发性甲状旁腺功能亢进发生的病因尚不清楚。为了研究这一问题,我们比较了接受原发性甲状旁腺功能亢进手术患者与接受良性甲状腺疾病手术患者的术前维生素D水平。经机构审查委员会批准,前瞻性收集了2006年3月至2011年7月间由一名外科医生进行甲状旁腺切除术或甲状腺切除术患者的数据。如果患者同时接受甲状腺和甲状旁腺手术、患有继发性或三发性甲状旁腺功能亢进、未测量术前维生素D水平或服用维生素D补充剂,则将其排除。219例行甲状旁腺切除术的患者和186例行甲状腺手术的患者符合纳入标准。收集了患者的年龄、性别、种族和术前维生素D水平(维生素D 25-OH;正常范围为32至100 pg/mL)。采用线性回归进行统计分析。甲状旁腺组的维生素D水平显著低于甲状腺组(23.8 vs 28.5 pg/mL;P < 0.001)。在对年龄、性别和种族进行调整后,也观察到了这种差异,平均差异为4.87 pg/mL(P < 0.001)。确定维生素D水平较低与年龄小于50岁的患者(P = 0.048)、男性(P = 0.03)和非白人种族之间存在统计学显著关联(P < 0.001)。与对照组手术人群相比,原发性甲状旁腺功能亢进患者更有可能维生素D水平较低。需要进一步研究以确定低维生素D水平是否可能是与甲状旁腺功能亢进发生相关的病因。